Company Search:
Advanced Search
Sponsored Links
Diaxonhit SA Company Snapshot
Diaxonhit SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Diaxonhit SA with three other pharmaceutical manufacturers in Europe: Mithra Pharmaceuticals SA of Belgium (2016 sales of 22.47 million Euro [US$25.19 million] ), Millet Innovation Sa (23.16 million Euro [US$25.97 million] of which 93% was Pharmacies & Pharmaceutical Wholesale De), and Biofarm SA which is based in Romania (152.12 million Romanian Leu [US$37.37 million] ).

Sales Analysis. During the year ended December of 2016, sales at Diaxonhit SA were 27.72 million Euro (US$31.07 million). This is a decrease of 5.9% versus 2015, when the company's sales were 29.46 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Diaxonhit SA
  Stock Performance Chart for Diaxonhit SA
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): .25
(Figures in Euro)
1 Week -3.8%   13 Weeks 0.0%  
4 Weeks 8.7%   52 Weeks -39.0%  
Diaxonhit SA Key Data:
  Ticker: ALEHT Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 27,718,000
(Year Ending Jan 2017).
Employees: 86
  Currency: Euro Market Cap: 19,467,721
  Fiscal Yr Ends: December Shares Outstanding: 77,870,883
  Share Type: Action Ordinaires Closely Held Shares: 1,075,289
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.